Products from TargetMol
TargetMol, based in Boston, Massachusetts, was founded in 2015 and is a drug screening expert in the life science community. The company offers diverse compound libraries, including FDA-approved libraries, and covers a broad spectrum of small molecule compounds such as inhibitors and agonists as well as recombinant proteins and natural products. TargetMol's products are used by researchers worldwide in areas such as cancer research, neurobiology, inflammation, immunology and metabolism.
More information at: www.targetmol.com
Item number: TGM-TQ0291-100mg
| Keywords: | SB 683699 |
| Application: | Targets integrin alpha 4 (ITGA4, CD49d) |
| CAS | 402567-16-2 |
| MW: | 499.5 D |
Item number: TGM-TQ0292-100mg
| Keywords: | AAT-007, CJ-023423, RQ-00000007 |
| Application: | Targets prostaglandin E receptor 4 (PTGER4) |
| CAS | 415903-37-6 |
| MW: | 491.61 D |
Item number: TGM-TQ0293-2mg
| Keywords: | MP-412 free base |
| Application: | EGFR / ErbB2 inhibitor |
| CAS | 451492-95-8 |
| MW: | 507 D |
Item number: TGM-TQ0295-10mg
| Application: | 17-beta-hydroxysteroid oxidoreductase inhibitor |
| CAS | 479-13-0 |
| MW: | 268.22 D |
Item number: TGM-TQ0296-20mg
| Application: | Alkaloid, cholinesterase inhibitory agent |
| CAS | 4846-19-9 |
| MW: | 281.35 D |
Item number: TGM-TQ0296L-100mg
| Keywords: | N-Nornuciferine hydrochloride |
| MW: | 317.81 D |
Item number: TGM-TQ0298-1mg
| Keywords: | D-Fagomine |
| CAS | 53185-12-9 |
| MW: | 147.17 D |
Item number: TGM-TQ0299-2mg
| Keywords: | 2-(Hexyloxy)benzamide |
| Application: | Antifungal |
| CAS | 53370-90-4 |
| MW: | 221.3 D |
Item number: TGM-TQ0300-100mg
| Application: | Irreversible glucocerebrosidase inhibitor |
| CAS | 6090-95-5 |
| MW: | 162.14 D |
Item number: TGM-TQ0301-1mg
| CAS | 62949-77-3 |
| MW: | 420.45 D |
Item number: TGM-TQ0302-1mg
| Application: | SERCA inhibitor, Ca2+ releaser |
| CAS | 67526-95-8 |
| MW: | 650.75 D |
Item number: TGM-TQ0306-100mg
| Application: | IKKbeta inhibitor |
| CAS | 783348-36-7 |
| MW: | 366.8 D |